| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.6177 | 44 |
| GSM780708 | Untreated after 4 days (C2_1) | 54.5318 | 59 |
| GSM780709 | Untreated after 4 days (C3_1) | 53.722 | 57 |
| GSM780719 | Untreated after 4 days (C1_2) | 53.432 | 57 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.0733 | 27 |
| GSM780721 | Untreated after 4 days (C3_2) | 53.462 | 57 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.2758 | 33 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 52.6761 | 55 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.1065 | 37 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 43.0705 | 18 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.8798 | 31 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.9891 | 54 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 55.0295 | 60 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.7378 | 56 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.6848 | 26 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.3709 | 38 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 55.5603 | 60 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 57.6351 | 63 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.7554 | 16 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.8159 | 54 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.5654 | 30 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.2688 | 33 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 55.6493 | 60 |